BMS Allogenic Manufacturing Asset Life Cycle Activity

CHA supported Bristol Myers Squibb’s Allogenic Manufacturing Asset Life Cycle Activity project by enhancing asset management and maintenance planning through detailed equipment documentation, on-site verification, and vendor coordination for spare parts and BOM development. The team conducted an Asset Criticality Assessment and a component-level review of BAS/QBAS systems, followed by a Critical Spares analysis to ensure operational reliability. All data was systematically integrated into the CMMS, laying the foundation for a proactive, efficient maintenance strategy.